Company Analysis

Syndax Pharmaceuticals, Inc. (SNDX)

Nasdaq: SNDX · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2007
Grade5.5
◀ Past 6.5● Present 4.5▶ Future 5.8
2 est.

Filings

315 filings since 2017 beside 251 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 33 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
4852706269446353
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Nov 2, 2026.SEC letters: 3 in the last 36 months, the newest Dec 7, 2023.
Insider forms 251

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 SCHEDULE 13G Large holder notice
Nov 2, 2026 10-Q Quarterly report Sep 30, 2026
Nov 2, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report
Aug 7, 2026 SCHEDULE 13G Large holder notice
Aug 4, 2026 10-Q Quarterly report Jun 30, 2026
Aug 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 14, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 10, 2026 8-K items 1.01, 2.03, 3.02, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Jun 10, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report
Jun 4, 2026 DEFA14A Extra proxy material
Jun 4, 2026 8-K items 1.01, 2.03, 3.02, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Other event · Current report Jun 3, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 30, 2026 SCHEDULE 13G Large holder notice
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEFA14A Extra proxy material
Apr 30, 2026 DEF 14A Proxy statement
Apr 30, 2026 10-Q Quarterly report Mar 31, 2026
Apr 30, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 26, 2026 S-8 Employee stock plan registration
Feb 26, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 9, 2026 SCHEDULE 13G Large holder notice
Jan 30, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 12, 2026 8-K items 2.02, 7.01 Results released; Investor disclosure (Regulation FD) · Current report
Dec 19, 2025 8-K item 5.03 Charter, bylaw or fiscal-year change · Current report Dec 18, 2025
Nov 3, 2025 10-Q Quarterly report Sep 30, 2025
Nov 3, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 24, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 18, 2025 SCHEDULE 13G Large holder notice
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 4, 2025 10-Q Quarterly report Jun 30, 2025
Aug 4, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 26, 2025 8-K item 5.02 Officer or director change · Current report Jun 24, 2025
May 16, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report May 12, 2025
May 9, 2025 SCHEDULE 13G/A Large holder update, amended
May 7, 2025 SCHEDULE 13G/A Large holder update, amended
May 5, 2025 10-Q Quarterly report Mar 31, 2025
May 5, 2025 8-K items 2.02, 8.01, 9.01 Results released; Other event · Current report
40 of 315 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton SNDX · research, not advice